Company intelligence / Profile preview

Zhongao Biomedical Technology

Guangdong, Chinamap.startuplithuania.lt ↗

Ownership: Private
Development stage: Commercial

Overview

Zhongao Biomedical Technology is a Chinese biotech company focused on developing synthetic peptides, therapeutic vaccines, and radiopharmaceuticals for oncology and infectious diseases. Its lead programs are in preclinical or IND application stages, with no reported clinical results yet. The company’s research includes combination immunotherapies using host-defense peptides to enhance immune checkpoint inhibitor efficacy in tumor models.

Therapeutic areas: Infectious DiseasesOncologyWomen's Health
Modalities: Synthetic peptideTherapeutic vaccineTherapeutic radiopharmaceuticalsRecombinant polypeptideChemical drugs
Industry: Biotech

Drug pipeline

7 assets

ZA005

Preclinical

6 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Zhongao Biomedical Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zhongao Biomedical Technology.

Explore the full profile